Answers are grounded in this paper and cite their sources.
BACKGROUND: Microbial exopolysaccharides represent a significant source of polysaccharides, with their production unconstrained by temporal or spatial limitations. Penicillium, a filamentous fungus widely recognized for its medicinal food applications, is known to produce exopolysaccharides that exhibit cancer-inhibitory properties. RESULTS: In the present study, exopolysaccharides from Penicillium EF-2 (EPS) were extracted and structurally characterized using ion chromatograph, infrared spectroscopy and NMR. The in vitro antioxidant and immunomodulatory activities were also investigated. EPS has a molecular weight of 111.47 kDa, is primarily composed of mannose, glucose and galactose, possesses a crystalline region, and exhibits excellent thermal properties. In free radical scavenging assays, EPS demonstrated robust in vitro antioxidant activity. Furthermore, EPS activated the mitogen-activated protein kinase pathway, enhancing the immunomodulatory capacity of macrophages. CONCLUSION: EPS has excellent antioxidant and biological activities. The present study provides a theoretical basis for the utilization of EPS and offers new ideas for active sources of Penicillium fermented foods.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: